At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 16, 2026 at 09:30 ET
Emergent BioSolutions Inc. filed its definitive proxy statement for the 2026 annual shareholder meeting, scheduled for April 29, 2026. The filing serves as a reminder for shareholders to vote on matters including director elections and executive compensation, with voting accessible via proxy.
- Filing is a Definitive Proxy Statement (DEFA14A) for the 2026 annual meeting.
- Annual meeting date is April 29, 2026, at 9:00 AM Eastern Time.
- Shareholders of record as of March 6, 2026, are eligible to vote.
- Voting can be completed by proxy, with instructions sent via email through E*TRADE.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access